Person who experienced the adverse event (patient)
Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
7205505 | 7583468 | F | 7205505-6 | 20101228 | 20101231 | EXP | PHHY2010CA59851 | NOVARTIS PHARMACEUTICAL CORPORATION | YR | M | Y | 20101231 | OT | CANADA |
Drug(s) used by person
Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
---|---|---|---|---|---|---|---|---|---|---|---|
7205505 | 1015449406 | PS | CLOZARIL | 1 | ORAL | 325 MG, QD | 019758 |
Indications of drugs used
Event ID | DRUG SEQ | INDI PT |
---|---|---|
7205505 | 1015449406 | SCHIZOPHRENIA |
Outcome of event
Event ID | OUTC COD |
---|---|
7205505 | DE |
Reactions reported
Event ID | PT |
---|---|
7205505 | MYOCARDITIS |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|
7205505 | 1015449406 | 20100415 | 20100909 | 148 | DAY |